Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids

Proc Natl Acad Sci U S A. 2022 Oct 11;119(41):e2203480119. doi: 10.1073/pnas.2203480119. Epub 2022 Oct 5.

Abstract

Fatty acids are an important source of energy and a key component of phospholipids in membranes and organelles. Saturated fatty acids (SFAs) are converted into unsaturated fatty acids (UFAs) by stearoyl Co-A desaturase (SCD), an enzyme active in cancer. Here, we studied how the dynamics between SFAs and UFAs regulated by SCD impacts ovarian cancer cell survival and tumor progression. SCD depletion or inhibition caused lower levels of UFAs vs. SFAs and altered fatty acyl chain plasticity, as demonstrated by lipidomics and stimulated Raman scattering (SRS) microscopy. Further, increased levels of SFAs resulting from SCD knockdown triggered endoplasmic reticulum (ER) stress response with brisk activation of IRE1α/XBP1 and PERK/eIF2α/ATF4 axes. Disorganized ER membrane was visualized by electron microscopy and SRS imaging in ovarian cancer cells in which SCD was knocked down. The induction of long-term mild ER stress or short-time severe ER stress by the increased levels of SFAs and loss of UFAs led to cell death. However, ER stress and apoptosis could be readily rescued by supplementation with UFAs and reequilibration of SFA/UFA levels. The effects of SCD knockdown or inhibition observed in vitro translated into suppression of intraperitoneal tumor growth in ovarian cancer xenograft models. Furthermore, a combined intervention using an SCD inhibitor and an SFA-enriched diet initiated ER stress in tumors growing in vivo and potently blocked their dissemination. In all, our data support SCD as a key regulator of the cancer cell fate under metabolic stress and point to treatment strategies targeting the lipid balance.

Keywords: ER stress; SRS imaging; fatty acids; lipid metabolism; ovarian cancer.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Cell Survival*
  • Disease Progression
  • Endoribonucleases*
  • Fatty Acid Desaturases
  • Fatty Acids / pharmacology
  • Fatty Acids, Unsaturated* / pharmacology
  • Female
  • Humans
  • Ovarian Neoplasms*
  • Phospholipids
  • Protein Serine-Threonine Kinases
  • Stearoyl-CoA Desaturase / metabolism

Substances

  • Fatty Acids
  • Fatty Acids, Unsaturated
  • Phospholipids
  • Fatty Acid Desaturases
  • Stearoyl-CoA Desaturase
  • Protein Serine-Threonine Kinases
  • Endoribonucleases